Respiratory and cardiovascular effects of buprenorphine in conscious rabbits.

OBJECTIVE To quantify the respiratory and cardiovascular effects of intravenous or subcutaneous buprenorphine in conscious rabbits. STUDY DESIGN Prospective experimental trial. ANIMALS Eight healthy, young adult New Zealand white rabbits (four female). METHODS Rabbits were instrumented with intraabdominal arterial and venous catheters and diaphragmatic electromyographic electrodes 2 weeks before experiments. Arterial blood pressure, arterial blood gases, heart rate and respiratory rate were monitored during experiments. Buprenorphine (0.06 mg) was administered either intravenously or subcutaneously to conscious rabbits. Respiratory and cardiovascular parameters were compared to baseline at 10 and 22 minutes after intravenous buprenorphine administration, and at 30, 60, and 90 minutes after subcutaneous buprenorphine administration. RESULTS Buprenorphine administration, at a dose of approximately 0.02 mg kg(-1), did not change blood pressure or heart rate. However, respiratory rate decreased from 252 +/- 26 to 39 +/- 26 breaths minute(-1) (mean +/- SD), and from 306 +/- 38 to 90 +/- 38 breaths minute(-1) following intravenous and subcutaneous administration of buprenorphine, respectively. Subsequent to intravenous and subcutaneous buprenorphine, arterial oxygen tension decreased from 88 +/- 4 to 72 +/- 4 mmHg (11.7 +/- 0.5 to 9.6 +/- 0.5 kPa) and from 87 +/- 3 to 77 +/- 3 mmHg (11.6 +/- 0.4 to 10.3 +/- 0.4 kPa), respectively. Buprenorphine, by either route of administration, increased arterial carbon dioxide tension from 36 to 41 mmHg (4.8-5.5 kPa) and increased the alveolar-arterial oxygen gradient from 15 to > or =20 mmHg (2 to > or =2.7 kPa). CONCLUSIONS AND CLINICAL RELEVANCE Buprenorphine administration decreased respiratory rate and produced mild hypoxemia in conscious rabbits. While these changes were well tolerated by healthy animals, caution should be exercised when administering buprenorphine to rabbits predisposed to respiratory depression.

[1]  J. Schadt,et al.  Effect of buprenorphine on the cardiovascular and respiratory response to visceral pain in conscious rabbits. , 2008, Veterinary anaesthesia and analgesia.

[2]  Rachel R. Strittmatter,et al.  A novel electrode design for chronic recording of electromyographic activity , 2006, Journal of Neuroscience Methods.

[3]  M. Danhof,et al.  Buprenorphine induces ceiling in respiratory depression but not in analgesia. , 2006, British journal of anaesthesia.

[4]  M. McKown,et al.  Noxious visceral stimulation and the response to blood loss in conscious rabbits , 2006 .

[5]  P. Macnaughton,et al.  Tests of pulmonary function , 2005 .

[6]  P A Flecknell,et al.  Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating post-operative pain in animals , 2002, Laboratory animals.

[7]  P. Flecknell,et al.  Chapter 5 – Management of Postoperative and Other Acute Pain , 2000 .

[8]  D. Blais,et al.  Effects of buprenorphine on cardiovascular and pulmonary function in clinically normal horses and horses with chronic obstructive pulmonary disease. , 1998, American journal of veterinary research.

[9]  H. Kotaki,et al.  Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. , 1997, The Journal of pharmacology and experimental therapeutics.

[10]  E. P. Smith,et al.  Cardiorespiratory effects of four opioid-tranquilizer combinations in dogs. , 1994, Veterinary surgery : VS.

[11]  S. Delpierre,et al.  Effects of buprenorphine on respiratory and cardiovascular functions during hypoxia in anaesthetized rabbits. , 1992, Archives internationales de pharmacodynamie et de therapie.

[12]  A. Waterman,et al.  Further studies on the antinociceptive activity and respiratory effects of buprenorphine in sheep. , 1991, Journal of Veterinary Pharmacology and Therapeutics.

[13]  P. Flecknell,et al.  Assessment of the analgesic action of opioid agonist-antagonists in the rabbit. , 1990 .

[14]  P. Flecknell,et al.  Reversal of fentanyl/fluanisone neuroleptanalgesia in the rabbit using mixed agonist/antagonist opioids , 1989, Laboratory animals.

[15]  C. D. West,et al.  An analgesiometry system for use in rabbits with some preliminary data on the effects of buprenorphine and lofentanil , 1988, Laboratory animals.

[16]  D. York,et al.  Routine, direct measurement of aortic pressure in the conscious rabbit , 1983, Physiology & Behavior.

[17]  P. Flecknell,et al.  Neuroleptanalgesia in the rabbit , 1983, Laboratory animals.

[18]  Colby Ed,et al.  Effect of xylazine and ketamine on blood pressure, heart rate and respiratory rate in rabbits. , 1980 .

[19]  A. Cowan,et al.  THE ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT , 1977, British journal of pharmacology.

[20]  D. Drury,et al.  THE RELATION OF THE LIVER TO FAT METABOLISM , 1929, The Journal of experimental medicine.